Objectives: In this study, alkaline phosphatase, osteocalcin, carboxy-terminal telopeptides of type I collagen, calcium, phosphorus, vitamin D, physical and psychological symptoms before and after treatment in vitex and sage extract group compared with the control group. Design: In this double-blind study of 100 postmenopausal women referred to hospital BMD Namazee(single core) by permutation block divided into three groups and blinding The idea is that participants with the contacts did not have the help of researcher Tablets black codes and put in jars to the researcher does not know what a pill each canister. Setting and conduct: First, personal information forms and a questionnaire about Menopause Rating Scale (MRS) and tests of osteogenic factors is performed and the above process is repeated after 3 months of intervention. Inclusion criteria: are osteopenic postmenopausal women who received calcium and vitamin D supplementation but do not receive other effective drugs on bone density. Interventions: the first intervention group is given, daily, one Agnugol tablets, 3.2- 4.8Mg(extract of VAC), the second group is given, daily, three Salvigol tablets, 100 Mg(Salvia officinalis extract), and the third group is given each day three placebo tablets.. Agnugol and Salvgl tablets are products Goldarou Company of Esfahan .main outcome: osteogenic factors - physical and mental symptoms.